
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[TXG] 10x Genomics Inc - Cl. A - Other Non-Current Liabilities
Data updated 2024-Mar-24 (Sunday)Note: Detailed Statistics for Other Non-Current Liabilities in Balance Sheet for 10x Genomics Inc - Cl. A [NASDAQ:TXG] with frequency distribution chart that analyze trends & history . Other Non-Current Liabilities include Deferred Taxes, Provisions for Risks etc. View Balance Sheet for broader context
Share
Quarterly Other Non-Current Liabilities values for 10x Genomics Inc - Cl. A are rounded to enhance readability
2023-Dec | 2023-Sep | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | |
---|---|---|---|---|---|---|
Other Non-Current Liabilities | 96.9 M | 10 M | 8 M | 7 M | 6 M | 5 M |
Sequential Quarter Growth | +869.4% | +25.0% | +14.3% | +16.7% | +20.0% | -44.4% |
Quarter-on Quarter Growth | +1,515.6% | +100.0% | -11.1% | -22.2% | -57.1% | -64.3% |
Annual Other Non-Current Liabilities values for 10x Genomics Inc - Cl. A are rounded to enhance readability
2023-Dec | 2022-Dec | 2022-Jan | 2021-Jan | 2020-Jan | 2019-Jan | |
---|---|---|---|---|---|---|
Other Non-Current Liabilities | 96.9 M | 6 M | 6 M | 14 M | 15 M | 103 M |
Year-on-Year Growth | +1,515.6% | 0.0% | -57.1% | -6.7% | -85.4% | +139.5% |
2-yr CAGR | +301.9% | -34.5% | -36.8% | -63.1% | -40.9% | |
3-yr CAGR | +90.6% | -26.3% | -61.2% | -31.2% | ||
4-yr CAGR | +59.4% | -50.9% | -38.9% | |||
5-yr CAGR | -1.2% | -32.6% |
Frequency distribution of quarterly Other Non-Current Liabilities values from 2019-Sep-30 grouped into buckets. Latest Other Non-Current Liabilities value is 96.9 Million as of 2023-Dec-31
Subsequent stock performance post earnings date till next announcement for 10x Genomics Inc - Cl. A mapped with quarterly Other Non-Current Liabilities values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Other Non-Current Liabilities above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for 10x Genomics Inc - Cl. A with subsequent post-earnings performance given Other Non-Current Liabilities values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (absolute perf.) | Outperform (absolute perf.) | |
---|---|---|
Other Non-Current Liabilities - Low | 53% | 47% |
Other Non-Current Liabilities - Medium | 74% | 26% |
Other Non-Current Liabilities - High | 53% | 47% |
Other Non-Current Liabilities (Sequential growth %) - Low | 69% | 31% |
Other Non-Current Liabilities (Sequential growth %) - Medium | 100% | 0% |
Other Non-Current Liabilities (Sequential growth %) - High | 22% | 78% |
Other Non-Current Liabilities (QoQ growth %) - Low | 63% | 37% |
Other Non-Current Liabilities (QoQ growth %) - Medium | 53% | 47% |
Other Non-Current Liabilities (QoQ growth %) - High | 77% | 23% |
Related to 10x Genomics Inc - Cl. A
Information for 10x Genomics Inc - Cl. A
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-05 on Google
SEC Reports : Quarterly reports around 2025-May-05 on SEC Edgar
Compare 10x Genomics Inc - Cl. A with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes 10x Genomics Inc - Cl. A
Industry : Equipment & Supplies industry performance which includes 10x Genomics Inc - Cl. A